1. ScholarBank@NUS
  2. 1. Staff
  3. Staff Publications
Please use this identifier to cite or link to this item: https://doi.org/10.1109/ICCABS.2011.5729904
DC FieldValue
dc.titlePoster: Modelling the tumor shrinkage pharmacodynamics with BlenX
dc.contributor.authorLecca, P.
dc.contributor.authorKahramanogullari, O.
dc.contributor.authorMorpurgo, D.
dc.contributor.authorPriami, C.
dc.contributor.authorSoo, R.A.
dc.date.accessioned2014-11-26T10:00:27Z
dc.date.available2014-11-26T10:00:27Z
dc.date.issued2011
dc.identifier.citationLecca, P.,Kahramanogullari, O.,Morpurgo, D.,Priami, C.,Soo, R.A. (2011). Poster: Modelling the tumor shrinkage pharmacodynamics with BlenX. 2011 IEEE 1st International Conference on Computational Advances in Bio and Medical Sciences, ICCABS 2011 : 251-. ScholarBank@NUS Repository. <a href="https://doi.org/10.1109/ICCABS.2011.5729904" target="_blank">https://doi.org/10.1109/ICCABS.2011.5729904</a>
dc.identifier.isbn9781612848525
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/110803
dc.description.abstractWe present a model written in BlenX language describing the lung tumor size changes over the time course of chemotherapy in human patients that are treated with gemcitabine and carboplatin. © 2011 IEEE.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1109/ICCABS.2011.5729904
dc.sourceScopus
dc.subjectBlenX
dc.subjectPharmacodynamics
dc.subjectTumor shrinkage
dc.typeConference Paper
dc.contributor.departmentCANCER SCIENCE INSTITUTE OF SINGAPORE
dc.description.doi10.1109/ICCABS.2011.5729904
dc.description.sourcetitle2011 IEEE 1st International Conference on Computational Advances in Bio and Medical Sciences, ICCABS 2011
dc.description.page251-
dc.identifier.isiutNOT_IN_WOS
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

1
checked on Mar 26, 2023

Page view(s)

119
checked on Mar 16, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.